An animal study published in 2006 in Arthritis and
Rheumatology demonstrated that a curcumin - rich turmeric extract inhibited joint inflammation and joint destruction, and prevented the expression of prostaglandins and of clyclooxygenase 2 — both pro-inflammatory substances.
Prof. Dr. Aline Bozec from Department of Medicine 3 —
Rheumatology and Immunology (director: Prof. Dr. Georg Schett) at Universitätsklinikum Erlangen was able to
demonstrate that increased activation of HIF - 1?
Professor Cyrus Cooper, Professor of
Rheumatology and Director of the MRC Lifecourse Epidemiology Unit, University of Southampton, added: «This study forms part of a larger programme of work addressing risk factors for fracture across the lifecourse, and
demonstrates the importance of the University of Southampton and MRC Lifecourse Epidemiology Unit in leading large, UK wide analyses on the internationally leading UK Clinical Practice Research Datalink dataset.
Smolen, Head of the Division of
Rheumatology at MedUni Vienna and the third most quoted rheumatology expert, and researchers from the USA, Argentina, Australia, the UK and China, were able to demonstrate that the combination of methotrexate / tofacitinib produced equally effective results as the current standard combination of methotrexate /
Rheumatology at MedUni Vienna and the third most quoted
rheumatology expert, and researchers from the USA, Argentina, Australia, the UK and China, were able to demonstrate that the combination of methotrexate / tofacitinib produced equally effective results as the current standard combination of methotrexate /
rheumatology expert, and researchers from the USA, Argentina, Australia, the UK and China, were able to
demonstrate that the combination of methotrexate / tofacitinib produced equally effective results as the current standard combination of methotrexate / adalimumab.